CHEST 2026
-
Experts debate balancing AI innovation with human connection in clinical care
Speakers and audience members weighed in for a high-spirited discussion about the potential benefits and risks of artificial intelligence in the clinical care setting.
-
Discussion to address ICU preparations for growing risk of climate-related mass casualty events
Climate-change crises, from heat domes to climate-driven infectious diseases, will increasingly test the readiness and resilience of critical care units everywhere, said Gabriel Bosslet, MD, FCCP.
-
Vital signs of victory: Meet the 2026 CHEST Challenge finalists
Get to know the pulmonary and critical care fellows who will compete tonight for top honors in the 25th year of the CHEST Challenge Championship.
-
Presentations to examine potential role of new medications in OSA treatment
The treatment landscape for OSA is evolving rapidly, moving beyond a one-size-fits-all approach toward therapies tailored to the underlying drivers of disease, said Patrick Strollo, MD, MS, FCCP.
-
Experts to present best practices for diagnosing and treating necrotizing pneumonia
When clinicians encounter necrotizing pneumonia in their practice, they must navigate a lack of clear diagnostic criteria and standardized management strategies, said Tracy T. Ashby, DO, FCCP.
-
Session aims to help critical care teams overcome dyssynchrony in invasive and noninvasive ventilation
Many physicians are familiar with using noninvasive modes of ventilation in chronic, stable outpatient cases, but the ICU presents different challenges, said Daniel Ouellette, MD, FCCP.
-
Countdown to 100: CHEST Travel Grants program reaches new heights
Thanks to the generosity of CHEST donors, 91 early career clinicians received travel grants to attend CHEST 2026. In addition to a $1,000 travel stipend, grant recipients receive complimentary registration to the meeting and the opportunity to meet and consult with a mentor.
-
Discussions to tackle barriers to equitable sleep care in Native and rural communities
Advancing sleep health equity can be challenging in populations where disproportionately high rates of sleep-disordered breathing are compounded by limited health care access, cultural barriers, and geographic isolation, said Christopher Lau, MD.
-
Agenda add-ons for Monday at CHEST 2026
Make the most of your day at the CHEST Annual Meeting with these extra items for your schedule. Discover even more recommendations in the CHEST Events mobile app, the CHEST 2026 magazine, and CHEST 2026: Inside Look.
-
Experts to focus on therapeutic potential of drug repurposing for IPF
In the age of machine learning and precision medicine, drug repurposing may be one way to complement new drug discovery in idiopathic pulmonary fibrosis (IPF), said Timothy Dempsey, MD, MPH, FCCP.













